Century Therapeutics, Inc. logo IPSC - Century Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $2.00 DETAILS
HIGH: $2.00
LOW: $2.00
MEDIAN: $2.00
CONSENSUS: $2.00
DOWNSIDE: 3.38%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 0 0 0 109.2 4.2 0.8 0.8 0.9 0.3 0.1 0.1 1.7 0.5 2.2 1.4 1.1 0 0 0 0 0 0 0 0
Cost of Revenue 0 3.0 0 22.5 26.9 0 0 0 0 0 22.3 22.8 0 2.2 3.4 0 0 0 1.9 1.0 0.9 0.9 0 0 0.3 0
Gross Profit 0 (3.0) 0 (22.5) (26.9) 109.2 4.2 0.8 0.8 0.9 (22.0) (22.6) 0.1 (0.5) (2.9) 2.2 1.4 1.1 (1.9) (1.0) (0.9) (0.9) 0 0 (0.3) 0
Operating Expenses
R&D Expenses 19.6 14.1 19.7 22.5 26.9 26.6 29.4 27.2 27.2 23.4 23.3 26.8 22.7 24.9 25.6 25.9 24.5 21.2 21.8 19.5 18.9 15.4 12.4 10.8 8.5 7.9
SG&A Expenses 5.8 6.6 1.0 6.8 7.8 8.4 7.8 8.4 8.3 8.7 8.6 9.0 8.2 6.7 4.9 8.1 8.3 7.3 4.3 5.2 3.2 1.7 2.8 2.3 2.0 2.0
Other Expenses 11.1 1.8 0 (15.8) (26.9) 0 4.3 0 0 0 (10.2) (22.8) 4.2 0 0 0 0 10 0 0 0 0 0 0 0 0
Operating Expenses 36.5 22.5 20.7 13.6 7.8 35.0 41.5 35.6 35.5 32.2 21.7 13.0 35.2 31.6 30.4 34.0 32.7 38.5 26.1 24.8 22.1 17.1 15.3 13.1 10.5 10.0
Operating Income
Operating Income (36.5) (25.5) (20.7) (36.1) (34.7) 74.2 (37.3) (34.8) (34.8) (31.3) (43.8) (35.6) (35.1) (32.1) (33.3) (31.7) (31.4) (37.4) (28.0) (25.8) (23.0) (18.1) (15.3) (13.1) (10.8) (10.0)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.1 0 0
Interest Income 2.0 2.0 1.3 1.6 2.0 2.4 2.9 3.3 3.6 3.2 3.5 3.5 3.1 2.6 0 0.0 0 0.2 0.3
Profitability
EBITDA (34.5) (18.6) (15.7) (26.2) (29.3) 79.8 (31.0) (27.9) (27.7) (24.8) (27.1) (28.3) (29.0) (27.5) (27.9) (27.7) (29.0) (36.1) (25.9) (24.6) (22.0) (17.1) (14.7) (12.6) (15.0) (9.5)
EBIT (34.5) (21.6) (19.2) (29.4) (32.5) 76.6 (34.3) (31.2) (31.2) (28.1) (30.6) (31.6) (32.2) (29.7) (31.2) (30.4) (30.7) (37.3) (27.8) (25.7) (23.0) (18.0) (15.2) (13.0) (15.3) (9.7)
Income Before Tax (34.5) (21.6) (19.2) (34.4) (32.5) 76.6 (34.3) (31.2) (31.2) (28.1) (40.3) (32.1) (32.3) (30.1) (31.6) (30.7) (31.0) (37.5) (28.2) (26.0) (23.3) (18.3) (15.5) (13.1) (15.3) (9.7)
Income Tax Expense 0 0 (0.1) 0 0 0 1.8 (0.0) 0.0 0.0 (0.9) 0.6 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0
Net Income (34.5) (21.6) (19.2) (34.4) (32.5) 76.6 (36.1) (31.2) (31.2) (28.1) (39.4) (32.7) (33.3) (31.3) (31.7) (30.7) (31.0) (37.5) (28.2) (26.0) (23.3) (18.3) (15.5) (13.1) (15.3) (9.7)
Per Share Data
EPS (Basic) -0.17 -0.25 -0.22 -0.40 -0.38 0.89 -0.46 -0.37 -0.38 -0.45 -0.66 -0.55 -0.56 -0.53 -0.54 -0.53 -0.54 -0.66 -0.52 -0.48 -0.43 -0.33 -0.37 -0.31 -0.37 -0.23
EPS (Diluted) -0.17 -0.25 -0.22 -0.40 -0.38 0.89 -0.46 -0.37 -0.38 -0.45 -0.66 -0.55 -0.56 -0.53 -0.54 -0.53 -0.54 -0.66 -0.52 -0.48 -0.43 -0.33 -0.37 -0.31 -0.37 -0.23
Shares Outstanding 205.8 86.6 86.6 86.5 86.2 86.0 78.6 84.7 82.1 62.3 59.9 59.4 59.3 58.6 58.3 58.0 57.4 57.1 54.5 54.5 54.4 54.8 41.8 41.8 41.8 41.8
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 49.6 51.0 61.9 55.5 56.9 51.9 58.4 52.6 41.5 46.8 47.3 55.3 64.4 86.8 84.3 111.3 112.8 126.0 56.4 101.3 272.3 79.5 27.2
Short-Term Investments 70.1 83.8 55.3 77.2 99.0 113.3 130.9 145.5 154.9 145.2 125.4 114.2 92.0 164.6 231.2 244.5 266.0 235.0 166.4 193.9 125.3 103.5 48.5
Net Receivables 0 0 0.7 0.5 0.6 1.0 1.5 1.3 0 0 0.7 1.7 1.7 1.5 0.8 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.9
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 1.4 1.7 4.5 3.7 3.5 0.9 6.5 1.8 1.6 1.8 0.1 0.2 0.2 0.5 0.6 2.4 3.2 2.8 2.2 1.3 1.8 1.8
Total Current Assets 124.8 139.0 120.8 137.7 160.2 169.6 194.1 206.0 203.5 199.8 177.0 173.7 161.3 255.9 319.7 361.6 383.8 365.3 228.2 300.4 402.6 185.3 78.8
Non-Current Assets
Property, Plant & Equipment 48.0 68.6 66.2 70.3 84.4 87.8 90.8 94.1 98.0 88.3 92.1 106.5 108.8 114.0 111.7 107.4 94.7 76.4 69.8 60.7 46.7 33.1 24.8
Goodwill 0 0 0 0 0 0 0 4.7 5.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 34.2 34.2 34.2 34.2 34.2 34.2 34.2 33.8 33.3 0 0 0 0 0 0 0 0 0 0 0 0 12.5 9.4
Long-Term Investments 77.5 82.2 2.4 2.3 2.7 23.5 30.8 49.4 76.1 57.9 91.1 116.7 146.6 85.3 51.9 39.4 50.6 105.4 135.9 105.2 42.5 63.1 1.1
Other Non-Current Assets 2.6 2.6 0.2 0.2 3.2 0.5 3.3 0.6 0.5 2.5 0.5 0.6 0.6 0.9 3.2 3.3 3.5 3.3 3.5 3.5 3.8 (8.0) (7.2)
Total Non-Current Assets 162.2 187.5 102.9 107.0 124.5 146.0 159.2 182.6 213.0 148.7 183.7 223.8 255.9 200.3 166.8 150.1 148.8 185.0 209.2 169.3 93.0 100.8 28.0
Total Assets 287.0 326.6 223.7 244.7 284.7 315.6 353.2 388.6 416.4 348.5 360.7 397.6 417.2 456.2 486.5 511.8 532.6 550.3 437.4 469.7 495.6 286.1 106.8
Current Liabilities
Account Payables 4.8 3.1 4.8 2.6 3.2 3.6 3.1 2.6 3.4 3.4 2.7 5.9 3.6 3.5 5.5 5.7 4.0 9.9 7.6 11.6 13.4 8.8 8.1
Short-Term Debt 0 0 0 3.8 0 4.9 0 3.8 0 0 1.5 2.0 1.2 10.9 6.5 4.0 1.6 0 1.0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 109.2 3.6 4.4 4.6 4.4 3.9 6.9 6.5 7.2 7.6 7.8 6.4 0 0 0 0 0
Other Current Liabilities 0 1.9 3.8 12.1 0.1 3.1 0.1 3.7 3.2 0.5 2.7 2.2 2.5 3.7 3.2 3.9 4.2 1.1 1.1 1.1 1.0 0.3 0.1
Total Current Liabilities 15.1 13.6 20.2 22.0 14.9 14.5 129.8 19.8 19.2 16.1 17.8 20.4 19.2 27.7 29.8 26.9 21.6 22.0 15.7 19.9 21.2 12.9 12.1
Non-Current Liabilities
Long-Term Debt 0 43.9 0 0 0 0 0 0 0 0 0 0 0 0 3.7 6.1 8.5 10.0 8.9 9.9 9.8 9.7 9.6
Deferred Tax Liabilities 4.3 4.3 4.3 4.4 4.4 4.4 4.4 3.5 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0.7 0 0 0.8 8.9 8.5 8.7 9.0 9.3 0.0 0.1 0.2 0.4 0.4 0.7 1.0 1.2 1.5 2.0 2.3 2.3 340.2 179.8
Total Non-Current Liabilities 39.6 48.2 44.5 46.3 59.8 60.7 62.1 173.1 175.2 154.6 158.1 157.9 150.4 151.4 154.0 154.6 153.1 141.7 25.5 26.9 26.8 364.7 201.1
Total Liabilities 54.7 61.8 64.8 68.4 74.8 75.2 191.9 192.9 194.3 170.6 175.9 178.3 169.6 179.1 183.8 181.5 174.6 163.6 41.1 46.7 48.0 377.6 213.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (848.1) (813.6) (791.9) (772.7) (738.3) (705.8) (782.3) (746.3) (715.0) (683.8) (655.8) (616.4) (583.7) (550.4) (519.1) (487.4) (456.7) (425.7) (388.2) (360.0) (334.0) (310.7) (292.3)
Accumulated Other Comprehensive Income (0.7) (0.6) 0.0 0.1 0.1 0.3 0.3 0.8 (0.3) (0.2) 0.1 (1.3) (1.2) (1.3) (2.5) (3.6) (3.4) (2.6) (0.7) (0.1) (0.0) (0.0) (0.0)
Total Stockholders' Equity 232.3 264.7 158.9 176.3 209.9 240.4 161.4 195.7 222.1 177.9 184.8 219.2 247.6 277.2 302.7 330.2 358.0 386.7 396.2 423.0 447.6 (91.6) (106.4)
Total Liabilities & Equity 287.0 326.6 223.7 244.7 284.7 315.6 353.2 388.6 416.4 348.5 360.7 397.6 417.2 456.2 486.5 511.8 532.6 550.3 437.4 469.7 495.6 286.1 106.8
Debt Metrics
Total Debt 34.6 48.0 43.6 45.0 51.5 52.7 53.8 54.6 56.4 46.5 48.2 47.6 42.0 52.0 49.4 47.3 41.2 25.0 25.1 25.3 25.1 25.1 21.6
Net Debt (15.0) (3.0) (18.3) (10.6) (5.4) 0.8 (4.6) 2.0 14.9 (0.3) 0.8 (7.7) (22.4) (34.8) (34.9) (64.1) (71.5) (101.0) (31.3) (76.0) (247.1) (54.4) (5.7)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (34.5) (21.6) (19.2) (34.4) (32.5) 76.6 (36.1) (31.2) (31.2) (28.1) (39.4) (32.7) (33.3) (31.3) (31.7) (30.7) (31.0) (37.5) (28.2) (26.0) (23.3) (18.3) (15.5) (13.1) (15.3) (9.7)
Depreciation & Amortization 2.6 3.0 3.5 3.1 3.2 3.2 3.3 3.3 3.5 3.2 3.6 3.4 3.2 2.9 2.8 2.8 1.7 1.2 1.1 1.0 0.9 0.7 0.5 0.4 0.3 0.2
Stock-Based Compensation 1.9 1.4 1.3 0.9 2.2 2.4 2.7 3.3 3.5 3.2 3.6 4.0 3.3 3.8 2.7 2.8 2.8 2.4 1.6 1.2 1.7 0.1 0.4 0.1 0.1 0.2
Change in Working Capital 0.6 (6.4) 3.2 (0.8) (0.5) (116.5) 1.8 (0.8) 0.7 (9.0) (2.9) 12.2 4.1 (4.0) 2.6 0.4 0.5 120.5 0.8 (0.5) 1.8 (4.9) 1.2 3.2 (1.8) 2.3
Other Non-Cash Items 9.5 (1.6) (4.8) 5.6 (0.0) (0.4) 5.8 (2.9) (3.8) 0.4 9.0 (0.4) (0.8) (0.7) 0.6 0.5 0.5 0.3 0.3 0.3 0.3 0.3 0.2 0.1 4.8 0.1
Operating Cash Flow (19.8) (25.2) (16.1) (25.6) (27.6) (34.6) (24.2) (28.3) (27.3) (30.2) (26.2) (13.6) (19.2) (29.2) (22.9) (24.2) (25.6) 86.8 (24.4) (24.0) (18.5) (22.2) (13.2) (9.2) (11.9) (6.9)
Investing Activities
Capital Expenditure (0.7) (0.6) (0.3) (0.2) (0.3) (0.5) (0.2) 0.8 (0.3) (0.5) (1.0) (3.3) (4.5) (5.0) (6.3) (9.8) (10.5) (4.1) (16.7) (15.7) (10.6) (1.9) (1.9) (4.5) (0.7) (2.7)
Acquisitions 0 0 0 0 0 0 (0.0) 0 0 0 0 (7.5) (11.5) (73.2) (238.2) (32.5) 0 (55.2) (30.3) 0 0 0 0 0 0 0
Purchases of Investments (16.0) (140.7) (9.7) (11.0) (9.7) (14.9) (17.4) (13.2) (53.9) (35.1) (9.7) (57.5) (99.0) (42.8) (50.3) (66.4) (34.2) (103.1) (41.9) (146.1) (17.2) (124.8) (36.9) (8.5) (2.9) (1.5)
Sales/Maturities of Investments 34.4 28.7 36.6 35.9 42.5 43.3 48.2 51.6 29.9 47.2 29.3 65.0 110.5 79.2 52.3 98.9 57.2 63.1 38.0 14.8 16.2 7.7 18.1 13.5 10.1 0
Other Investing Activities 0.1 0 (4.2) 0 0 0 0 0 (9.6) 0 0 7.5 11.5 73.2 238.2 32.5 0 55.2 30.3 0 0 0 0 0 (4.7) 0
Investing Cash Flow 17.8 (112.6) 22.4 24.7 32.5 27.9 30.6 39.2 (33.9) 11.5 18.6 4.2 7.0 31.3 (4.3) 22.7 12.5 (44.0) (20.6) (147.1) (11.6) (119.0) (20.8) 0.5 1.7 (4.2)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 126.2 0 0 0 0 0 (17.8) 0.7 0 0 0 0 (10.2) 0 0 0 0 0 0.0 0.0 2.7 33.8 38.1 (0.1) (0.0) 0
Financing Cash Flow 0.3 126.6 0.1 0 0 0.1 (0.6) 0.3 56.7 18.2 (0.4) 0.3 (10.1) 0.4 0.1 0.1 0.0 26.9 0.1 (0.5) 224.6 193.5 38.1 9.6 (0.0) 0
Cash Position
Net Change in Cash (1.8) (11.3) 6.3 (0.9) 4.9 (6.6) 5.8 11.1 (4.5) (0.5) (8.0) (9.1) (22.4) 2.6 (27.1) (1.4) (13.0) 69.6 (44.8) (171.5) 194.5 52.3 4.1 0 (10.2) (11.1)
Cash at Beginning 53.8 62.7 58.7 59.6 54.6 61.2 52.6 44.3 48.8 49.3 57.3 66.4 88.8 86.2 113.3 114.8 127.8 58.2 103.0 274.5 80 27.7 23.6 0 33.0 44.1
Cash at End 52.0 51.4 65.0 58.7 59.6 54.6 58.4 55.4 44.3 48.8 49.3 57.3 66.4 88.8 86.2 113.3 114.8 127.8 58.2 103.0 274.5 80 27.7 0 22.8 33.0
Free Cash Flow (20.5) (25.8) (16.4) (25.8) (27.9) (35.1) (24.4) (27.5) (27.6) (30.8) (27.2) (16.9) (23.8) (34.2) (29.2) (34.1) (36.0) 82.7 (41.1) (39.7) (29.1) (24.1) (15.1) (13.7) (12.7) (9.6)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 0 0 0 109.2 4.2 0.8 0.8 0.9 0.3 0.1 0.1 1.7 0.5 2.2 1.4 1.1 0 0 0 0 0 0 0 0
Gross Profit 0 (3.0) 0 (22.5) (26.9) 109.2 4.2 0.8 0.8 0.9 (22.0) (22.6) 0.1 (0.5) (2.9) 2.2 1.4 1.1 (1.9) (1.0) (0.9) (0.9) 0 0 (0.3) 0
Operating Income (36.5) (25.5) (20.7) (36.1) (34.7) 74.2 (37.3) (34.8) (34.8) (31.3) (43.8) (35.6) (35.1) (32.1) (33.3) (31.7) (31.4) (37.4) (28.0) (25.8) (23.0) (18.1) (15.3) (13.1) (10.8) (10.0)
Net Income (34.5) (21.6) (19.2) (34.4) (32.5) 76.6 (36.1) (31.2) (31.2) (28.1) (39.4) (32.7) (33.3) (31.3) (31.7) (30.7) (31.0) (37.5) (28.2) (26.0) (23.3) (18.3) (15.5) (13.1) (15.3) (9.7)
EPS (Diluted) -0.17 -0.25 -0.22 -0.40 -0.38 0.89 -0.46 -0.37 -0.38 -0.45 -0.66 -0.55 -0.56 -0.53 -0.54 -0.53 -0.54 -0.66 -0.52 -0.48 -0.43 -0.33 -0.37 -0.31 -0.37 -0.23
Balance Sheet
Cash & Equivalents 49.6 51.0 61.9 55.5 56.9 51.9 58.4 52.6 41.5 46.8 47.3 55.3 64.4 86.8 84.3 111.3 112.8 126.0 56.4 101.3 272.3 79.5 27.2
Total Assets 287.0 326.6 223.7 244.7 284.7 315.6 353.2 388.6 416.4 348.5 360.7 397.6 417.2 456.2 486.5 511.8 532.6 550.3 437.4 469.7 495.6 286.1 106.8
Total Debt 34.6 48.0 43.6 45.0 51.5 52.7 53.8 54.6 56.4 46.5 48.2 47.6 42.0 52.0 49.4 47.3 41.2 25.0 25.1 25.3 25.1 25.1 21.6
Stockholders' Equity 232.3 264.7 158.9 176.3 209.9 240.4 161.4 195.7 222.1 177.9 184.8 219.2 247.6 277.2 302.7 330.2 358.0 386.7 396.2 423.0 447.6 (91.6) (106.4)
Cash Flow
Operating Cash Flow (19.8) (25.2) (16.1) (25.6) (27.6) (34.6) (24.2) (28.3) (27.3) (30.2) (26.2) (13.6) (19.2) (29.2) (22.9) (24.2) (25.6) 86.8 (24.4) (24.0) (18.5) (22.2) (13.2) (9.2) (11.9) (6.9)
Capital Expenditure (0.7) (0.6) (0.3) (0.2) (0.3) (0.5) (0.2) 0.8 (0.3) (0.5) (1.0) (3.3) (4.5) (5.0) (6.3) (9.8) (10.5) (4.1) (16.7) (15.7) (10.6) (1.9) (1.9) (4.5) (0.7) (2.7)
Free Cash Flow (20.5) (25.8) (16.4) (25.8) (27.9) (35.1) (24.4) (27.5) (27.6) (30.8) (27.2) (16.9) (23.8) (34.2) (29.2) (34.1) (36.0) 82.7 (41.1) (39.7) (29.1) (24.1) (15.1) (13.7) (12.7) (9.6)